Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FIVE✓SelectedUSD · FIVEGSK vs FIVE performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs FIVE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+109.4%
FIVE return
+496.3%
Excess return
-386.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioFIVEExcessAlpha
1D-0.1%-2.1%+2.0%+0.1%
7D-1.3%-4.8%+3.5%-0.9%
30D+2.7%+8.5%-5.7%+1.9%
3M+2.7%-1.2%+3.9%+2.7%
6M+3.3%+13.1%-9.7%+1.8%
YTD+6.5%+28.2%-21.8%+3.4%
1Y+10.7%+64.3%-53.6%+5.0%
3Y+64.4%+34.2%+30.2%+56.0%
5Y+46.7%+10.4%+36.3%+39.9%
10Y+109.4%+498.5%-389.2%+61.4%
All+109.4%+496.3%-386.9%+61.4%

Cumulative growth

Daily Returns

Daily percentage return beside FIVE.

Daily Out/Under-Performance

Portfolio return minus FIVE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FIVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded FIVE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling